# Core Scientific, Inc./tx (CORZ) FY2026 Q2 Balance Sheet

- Company: Core Scientific, Inc./tx (CORZ)
- Period: As of 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-07-28, accession number 0001839341-26-000014
- Page: https://plicit.ai/financials/corz/fy2026-q2-balance-sheet
- Chart image: https://plicit.ai/charts/corz-fy2026-q2-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

- **Assets**: 5,257,493,000 US dollars
- **Current assets**: 2,443,644,000 US dollars
- **Non-current assets**: 2,813,849,000 US dollars
- **Liabilities**: 7,676,849,000 US dollars
- **Current liabilities**: 2,737,794,000 US dollars
- **Non-current liabilities**: 4,939,055,000 US dollars
- **Equity**: negative 2,419,356,000 US dollars
- **Cash and cash equivalents**: 1,769,735,000 US dollars
- **Customer funding receivable and other current assets**: 458,489,000 US dollars
- **Restricted cash, current portion**: 165,745,000 US dollars
- **Digital assets**: 49,675,000 US dollars
- **Property, plant and equipment, net**: 1,774,142,000 US dollars
- **Restricted cash, net of current portion**: 615,911,000 US dollars
- **Intangibles, net**: 228,625,000 US dollars
- **Operating lease right-of-use assets**: 114,199,000 US dollars
- **Other noncurrent assets**: 80,972,000 US dollars
- **Warrant liabilities, current portion**: 1,811,587,000 US dollars
- **Accrued expenses**: 509,189,000 US dollars
- **Deferred revenue**: 287,201,000 US dollars
- **Accounts payable**: 112,374,000 US dollars
- **Other current liabilities**: 17,443,000 US dollars
- **Long-term debt**: 4,297,967,000 US dollars
- **Deferred revenue, net of current portion**: 367,242,000 US dollars
- **Warrant liabilities, net of current portion**: 163,683,000 US dollars
- **Other noncurrent liabilities**: 110,163,000 US dollars
- **Additional paid-in capital**: 3,229,842,000 US dollars
- **Common stock; $0.00001 par value; 10,000,000 shares authorized at June 30, 2026 and December 31, 2025; 319,587 and 314,231 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively**: 3,000 US dollars
- **Preferred stock; $0.00001 par value; 2,000,000 shares authorized; none issued and outstanding at June 30, 2026 and December 31, 2025**: 0 US dollars
- **Accumulated deficit**: negative 5,649,201,000 US dollars

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.